PURPOSE To evaluate safety and efficacy of delayed intraarterial urokinase therapy with
mechanical disruption of clot to treat thromboembolic stroke. METHODS Thirteen patients …

Background and Purpose—We sought to evaluate predictors of clinical outcome,
angiographic success, and adverse effects after intra-arterial administration of urokinase for …

OBJECTIVE The National Institute of Neurological Disorders and Stroke (NINDS)
Recombinant Tissue Plasminogen Activator Stroke Study Group showed that recombinant …

Purpose A preliminary evaluation of the efficacy and safety of treating patients with acute
stroke with intraarterial urokinase infusions was performed. Patients and Methods Twelve …

Intravenous fibrinolysis (IVF) with rt-PA (alteplase) provides significant benefits in acute
ischaemic stroke when it is given within the first three hours following stroke onset. Intra …

BACKGROUND AND PURPOSE: Since the approval of intravenous tissue plasminogen
activator for acute ischemic stroke, great interest has been generated in cerebral fibrinolysis …

Background: The PROACT II trial showed that intra-arterial thrombolysis (IAT) is effective for
treatment of acute ischaemic stroke attributable to M1 and M2 segment occlusions …

OBJECTIVE: To determine the feasibility of combined intravenous and intra-arterial
thrombolytic therapy for acute ischemic strokes and to evaluate its associated risks, using …

Intraarterial administration of urokinase using Tracker microcatheter was performed in 11
patients with acute cerebral infarction caused by embolic occlusion of the internal carotid or …

BACKGROUND AND PURPOSE: Early reocclusion of recanalized arteries has been
observed after thrombolysis for acute coronary occlusion and has been attributed to platelet …